Company Filing History:
Years Active: 2017-2020
Title: Per Jonas Malmborg: Innovator in NMDA Antagonist Prodrugs
Introduction
Per Jonas Malmborg is a notable inventor based in Linköping, Sweden. He has made significant contributions to the field of pharmacology, particularly in the development of NMDA antagonist prodrugs. With a total of 3 patents, his work focuses on innovative treatments for depression and pain management.
Latest Patents
Malmborg's latest patents include prodrugs of an NMDA antagonist, specifically (S)-1-phenyl-2-(pyridin-2-yl)ethanamine. These prodrugs are designed to be useful in treating major depressive disorder and pain. The compositions he has developed, along with methods for making them, represent a significant advancement in therapeutic options for patients suffering from these conditions.
Career Highlights
Throughout his career, Malmborg has been associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative drug development, contributing to the advancement of medical science.
Collaborations
Some of his notable coworkers include Gunnar Nordvall and Annika Kers. Their collaborative efforts have further enhanced the research and development of new therapeutic solutions.
Conclusion
Per Jonas Malmborg's contributions to the field of pharmacology through his innovative patents highlight his commitment to improving treatment options for depression and pain. His work continues to influence the landscape of medical research and development.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.